Autoimmunity has been proposed to play a role in the pathogenesis of the nonspecific abdominal aortic aneurysm (AAA). [1] [2] [3] Histologic examination of AAA specimens has also revealed Russell bodies, which are hallmarks of autoimmunity, as in Hashimoto's thyroiditis. 3 In the spectrum of autoimmune disorders certain HLA alleles play a key role in the presentation of self proteins as autoantigens in different specific conditions. 4 For example, among the vasculitic disorders, giant cell arteritis appears to be related to the HLA-DRB1*04 allele. [5] [6] In AAA two reports have suggested the presence of specific susceptibility HLA-aneurysm, Takayasu arteritis, Behcet disease, and dissecting aneurysm were not included in this study. Patients with a clinical diagnosis of inflammatory aneurysm also were not included. Data for the following parameters were collected: age at diagnosis of AAA, sex, size of aneurysm, type of presentation (ruptured or nonruptured), and associated medical problems.
HLA typing. HLA antigen typing was performed in the Mitsubishi Biochemical Laboratory (MBC, Tokyo, Japan). In brief, the basic protocol at the MBC was to separate B cells from the peripheral blood with microbeads 9 and then to determine by the DR haplotypes lymphocyte inhibition tests with rabbit anti-human HLA antigen antibodies.
Statistical analysis. The frequency of HLA-DRB1 antigens of the patients were compared with those of the members of the control group with χ 2 tests.
RESULTS
Demographic data. Forty-six patients with AAA and 50 members of the control group were studied. The AAA group consisted of 39 men and 7 women with an age distribution from 47 to 89 years (mean, 71.6 years). The control group consisted of 41 men and 9 women with a slightly lower age distribution (41 to 85 years, mean, 67.3 years) than the AAA group. Three AAAs were ruptured, and the others were intact infrarenal AAAs with diameters ranging from 4 cm to 10 cm with a mean of 5.79 ± 1.45 cm (±SD). No significant differences were observed between the two groups in terms of associated medical problems, as shown in Table I .
HLA typing. The results of HLA typing are shown in Table II . The frequency of HLA DR2(15) in the AAA group was significantly greater than in the control group, with p < 0.005. No other differences reached statistical significance. Sex, age at diagnosis, size of aneurysm, and rupture status were compared between the DR2(15) positive group and the patients who were DR2(15)-negative. The results are shown in Table III . No significant differences were detected.
DISCUSSION
Autoimmune diseases are frequently associated with certain HLA DR types. HLA-DRB1*0401 is known to be important in the development of rheumatoid arthritis. 6 Weyand et al. 5 have reported that 98 (96%) of 102 patients express one of the major North American disease-linked polymorphisms (*04, *0101, or *1402). Forty-seven patients carried a double dose of the relevant sequence. Nodular disease was expressed in 100% of the patients with homozygous HLA-DR B1 *04/04. Thus patients with a double dose of a major susceptibility allele tend to have more severe manifestations of rheumatoid disease.
Although clinical differences in the HLA DR2(15) positive and negative groups among the patients with AAA did not reach statistical significance, a tendency was observed that more female patients with AAA were DR2(15) positive, and more ruptured cases were also DR2(15) positive. Because of perioperative mortality among the ruptured cases, it was not possible to get consent from patients with ruptured AAA. Accordingly, the true incidence of the HLA DR2(15) positive rate among the patients with ruptured AAAs is unknown.
The current findings are partially confirmatory of the two HLA studies from North America. The two previous studies and these results include HLA-2(15) as a genetic risk factor for the AAA disease. 7, 8 The previous studies also suggested that additional DR alleles may be important. Tilson et al. 7 predicted that in addition to DR2, 12, and 13, DR3 and 11 would also be susceptibility alleles based on their amino acid sequences in the hypervariable region. HLA-DR6 includes both DR13 and DR14 in this study, but because of technical limitations they are not differentiated here. If DR15, DR6, and DR12 are considered to be the high-risk serotypes in this population, it is noteworthy that 78% of the patients with AAA in this study had one of these types. Twelve patients with AAA and 6 patients in the control group were positive for a double dose of one of these high-risk serotypes (p = 0.077). It is interesting that two out of three cases of ruptured AAA had double doses.
The HLA typing was done in serologic fashion in this study, not by DNA typing. HLA-DR2(15) further classified DRB1*1501, 1502, 1503, and DR51 based on the DRB1 locus and DRB5 locus. 10 Further studies will be necessary to differentiate these genetic subtypes of the HLA-DR2(15) in patients with AAA.
This study is limited to a regional Japanese population, so it is curious that the results are not inconsistent with the previous North American studies. The frequencies of the haplotypes are similar throughout the islands of Japan because of the single race and geographically isolated region. It would be interesting in the future to determine whether the similar findings apply to Japanese living abroad, for example, in Hawaii.
Screening for AAA by ultrasonography in the HLA-DR2(15) positive population might focus more accurately on one group of subjects who would be most likely to benefit from early detection and aneurysm repair. 
